The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Contribution of Angiogenesis to Inflammation and Cancer
Open accessAbstract
During carcinogenesis, advanced tumors are surrounded by both stromal and immune cells, which support tumor development. In addition, inflammation and angiogenesis are processes that play important roles in the development of cancer, from the initiation of carcinogenesis, tumor in situ and advanced stages of cancer. During acute inflammation, vascular hyperpermeability allows inflammatory mediators and immune response cells, including leukocytes and monocytes/macrophages, to infiltrate the site of damage. As a factor that regulates vascular permeability, vascular endothelial growth factor (VEGF) also plays a vital role as a multifunctional molecule and growth factor. Furthermore, stromal and immune cells secrete soluble factors that activate endothelial cells and favor their transmigration to eliminate the aggressive agent. In this review, we present a comprehensive view of both the relationship between chronic inflammation and angiogenesis during carcinogenesis and the participation of endothelial cells in the inflammatory process. In addition, the regulatory mechanisms that contribute to the endothelium returning to its basal permeability state after acute inflammation are discussed. Moreover, the manner in which immune cells participate in pathological angiogenesis release pro-angiogenic factors that contribute to early tumor vascularization, even before the angiogenic switch occurs, is also examined. Also, we discuss the role of hypoxia as a mechanism that drives the acquisition of tumor hallmarks that make certain cancers more aggressive. Finally, some combinations of therapies that inhibit the angiogenesis process and that may be a successful strategy for cancer patients are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 7×
“While the precise activation mechanism is not fully known, it has been reported that exposure of the endothelium to various factors, such as histamine and VEGF-A, results in the activation of VVO transport (25).”
BackgroundInfluentialWound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 2×
“In addition, hypoxia increases cellular proliferation and the avoidance of apoptosis, which contributes to the chemoresistance of tumors (71).”
BackgroundMicroenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847 · cited 1×
“During these processes, cells release a plethora of angiogenic factors, including fibroblast growth factor (FGF)2, CXCL8,WNT7b, ANGPT2, IL-1β, IL-6, IFN-γ, CXCL9/10, and MMP2/9 (32).”
BackgroundChronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Inflammation and wound healing: the role of the macrophage
Koh, T. J., & DiPietro, L. A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001943 · Cited by 1,667
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Pathophysiology of acute wound healing
Li, J., Chen, J., & Kirsner, R. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.09.007 · Cited by 1,486
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,424
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Inflammatory cells during wound repair: the good, the bad and the ugly
Martin, P., & Leibovich, S. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.09.002 · Cited by 1,340 · cited 1×
“In addition, neutrophils are removed by efferocytosis (44, 45).”
BackgroundVascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici, C. S., Boşca, A. B., Șușman, S., Mărginean, M. V., Mihu, C., Istrate, M., Moldovan, I. M., Roman, A. L., & Mihu, C. M. (2018) · PubMed · Cited by 1,146
Diabetes and Wound Angiogenesis
Okonkwo, U., & DiPietro, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071419 · Cited by 1,022
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Antiangiogenic therapy in oncology: current status and future directions
Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01088-0 · Cited by 828
DNA Replication Stress as a Hallmark of Cancer
Macheret, M., & Halazonetis, T. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040424 · Cited by 823
Helicobacter pylori-induced gastric inflammation and gastric cancer
Wang, F., Meng, W., Wang, B., & Qiao, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.08.016 · Cited by 793
Shibuya, M. (2013) · Journal of Biochemistry · doi:10.1093/jb/mvs136 · Cited by 792
The crucial roles of inflammatory mediators in inflammation: A review
Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018) · Veterinary World · doi:10.14202/vetworld.2018.627-635 · Cited by 775
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 759
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Terme, M., Pernot, S., Marcheteau, E., Sandoval, F., Benhamouda, N., Colussi, O., Dubreuil, O., Carpentier, A. F., Tartour, E., & Taieb, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2325 · Cited by 684
Resolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Vascular permeability, vascular hyperpermeability and angiogenesis
Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M., & Dvorak, H. F. (2008) · Angiogenesis · doi:10.1007/s10456-008-9099-z · Cited by 628
Generation and Biological Activities of Oxidized Phospholipids
Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., Levonen, A.-L., Binder, C. J., & Stöckl, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2597 · Cited by 610
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
Zhong, Z., Sanchez-Lopez, E., & Karin, M. (2016) · Cell · doi:10.1016/j.cell.2016.05.051 · Cited by 576
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566
Ostrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.
Quatromoni, J. G., & Eruslanov, E. B. (2012) · Europe PMC (PubMed Central) · Cited by 453
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 440
Natural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., & Yuan, S. Y. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001112 · Cited by 380
Steven, A., Fisher, S. A., & Robinson, B. W. (2016) · Respirology · doi:10.1111/resp.12789 · Cited by 338
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Showalter, A., Limaye, A., Oyer, J. L., Igarashi, R., Kittipatarin, C., Copik, A. J., & Khaled, A. R. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.024 · Cited by 319
Vascular permeability—the essentials
Claesson-Welsh, L. (2015) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1064501 · Cited by 304
Inflammation and the Blood Microvascular System
Pober, J. S., & Sessa, W. C. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016345 · Cited by 302
Blood cells and endothelial barrier function
Rodrigues, S. F., & Granger, D. N. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.978720 · Cited by 284
FOLBERG, R., & MANIOTIS, A. J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0810.x · Cited by 275
Donnem, T., Hu, J., Ferguson, M., Adighibe, O., Snell, C., Harris, A. L., Gatter, K. C., & Pezzella, F. (2013) · Cancer Medicine · doi:10.1002/cam4.105 · Cited by 275
Munn, L. L. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1370 · Cited by 257
Danger signalling during cancer cell death: origins, plasticity and regulation
Garg, A. D., Martin, S., Golab, J., & Agostinis, P. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.48 · Cited by 226
A brief history of cancer: Age‐old milestones underlying our current knowledge database
Faguet, G. B. (2014) · International Journal of Cancer · doi:10.1002/ijc.29134 · Cited by 220
GRP78 at the Centre of the Stage in Cancer and Neuroprotection
Casas, C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00177 · Cited by 220
Immunomodulatory Activity of VEGF in Cancer
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.09.007 · Cited by 194
Disorders of Vascular Permeability
Park-Windhol, C., & D'Amore, P. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044506 · Cited by 190
Microvascular remodeling and wound healing: A role for pericytes
Dulmovits, B. M., & Herman, I. M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.031 · Cited by 187
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 184
Georgescu, S. R., Mitran, C. I., Mitran, M. I., Caruntu, C., Sarbu, M. I., Matei, C., Nicolae, I., Tocut, S. M., Popa, M. I., & Tampa, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/5315816 · Cited by 174
Vascular Hyperpermeability, Angiogenesis, and Stroma Generation
Nagy, J. A., Dvorak, A. M., & Dvorak, H. F. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006544 · Cited by 165
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Herzberg, B., Campo, M. J., & Gainor, J. F. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0189 · Cited by 164
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00069 · Cited by 163
Tumor-Elicited Inflammation and Colorectal Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.014 · Cited by 161
Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis
Kreuger, J., & Phillipson, M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.2 · Cited by 160
Brockmann, L., Giannou, A. D., Gagliani, N., & Huber, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051033 · Cited by 160
Interleukins 1 and 6 as main mediators of inflammation and cancer
Dmitrieva, O., Shilovskiy, I. P., Khaitov, M. R., & Grivennikov, S. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020024 · Cited by 155
Cellular and molecular regulation of vascular permeability
Goddard, L. M., & Iruela‐Arispe, M. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-09-0678 · Cited by 154
Role of Endothelial Chemokines and Their Receptors during Inflammation
Speyer, C. L., & Ward, P. A. (2011) · Journal of Investigative Surgery · doi:10.3109/08941939.2010.521232 · Cited by 145
Redundant angiogenic signaling and tumor drug resistance
Gacche, R. N., & Assaraf, Y. G. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.002 · Cited by 144
Angiogenesis in Inflammatory Bowel Disease
Alkim, C. A., Alkım, H., Köksal, A. R., Boğa, S., & Şen, İ. (2015) · International Journal of Inflammation · doi:10.1155/2015/970890 · Cited by 140
Proliferative retinopathies: Angiogenesis that blinds
Sapieha, P. S., Hamel, D., Shao, Z., Rivera, J. C., Zaniolo, K., Joyal, J., & Chemtob, S. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.006 · Cited by 132
Botrel, T. E. A., Clark, L. G. D. O., Paladini, L. M., & Clark, O. A. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2734-y · Cited by 130
Choi, B.-J., Park, S., Lee, S., Nam, Y., & Surh, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-15139-5 · Cited by 123
Okada, F. (2014) · PubMed · Cited by 117
Rho, S.-S., Ando, K., & Fukuhara, S. (2017) · Journal of Nippon Medical School · doi:10.1272/jnms.84.148 · Cited by 114
Cell Death and Inflammation – A Vital but Dangerous Liaison
Peltzer, N., & Walczak, H. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.03.006 · Cited by 110
VEGF receptor signal transduction – A brief update
Claesson, L. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.011 · Cited by 109
Filippi, M. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.09.001 · Cited by 106
Cao, Y., Li, C.-Y., Moeller, B. J., Yu, D., Zhao, Y., Dreher, M. R., Shan, S., & Dewhirst, M. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4553 · Cited by 92
Inflammation and Cancer: The role of the immune response and angiogenesis
Dalgleish, A. G., & O'Byrne, K. J. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_1 · Cited by 91
Toh, J. W. T., SOUZA, P. D., Lim, S. H.-S., Singh, P., Chua, W. M., Ng, W. L., & Spring, K. J. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.07.007 · Cited by 85
The functional and prognostic implications of regulatory T cells in colorectal carcinoma.
Zhang, X., Kelaria, S., Kerstetter, J. C., & Wang, J. (2015) · PubMed · doi:10.3978/j.issn.2078-6891.2015.017 · Cited by 81
Maloney, J. P., & Gao, L. (2015) · Mediators of Inflammation · doi:10.1155/2015/387842 · Cited by 80
Cancer: We Should Not Forget The Past
Lonardo, A. D., Nasi, S., & Pulciani, S. (2014) · Journal of Cancer · doi:10.7150/jca.10336 · Cited by 71
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 69
Wu, Y. S., Shui, L., Shen, D., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.12926 · Cited by 68
Induced Nitric Oxide Synthase as a Major Player in the Oncogenic Transformation of Inflamed Tissue
Yang, G., Taboada, S., & Liao, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-530-9_8 · Cited by 61
Ribatti, D. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103216dr · Cited by 60
Anuja, K., Roy, S., Ghosh, C., Gupta, P., Bhattacharjee, S., & Banerjee, B. (2016) · Inflammation Research · doi:10.1007/s00011-016-0985-3 · Cited by 59
Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy
Dunleavey, J. M., & Dudley, A. C. (2012) · Current Angiogenesis · doi:10.2174/2211552811201020133 · Cited by 56
Antiangiogenic therapy: Markers of response, “normalization” and resistance
Alaoui‐Lasmaili, K. E., & Faivre‐Fiorina, B. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.001 · Cited by 55
Lipid mediators in the regulation of endothelial barriers
Karki, P., & Birukov, K. G. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1385573 · Cited by 50
Speck‐Hernandez, C. A., & Montoya-Ortiz, G. (2012) · Arthritis · doi:10.1155/2012/604187 · Cited by 36
Intercellular communication for innate immunity
Nguyen, T. A., Pang, K. C., & Masters, S. L. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.002 · Cited by 35
Schmid, B. C., & Oehler, M. K. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0318-0 · Cited by 27
Introduction: T Cell Trafficking in Inflammation and Immunity
Chimen, M., Apta, B. H. R., & McGettrick, H. M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6931-9_6 · Cited by 22
Perspective on the dynamics of cancer
Derbal, Y. (2017) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-017-0066-5 · Cited by 18
Agostino, N. M., Saraceni, C., Kincaid, H. M., Shi, W., Nevala, W. K., Markovic, S. N., & Nair, S. (2015) · SpringerPlus · doi:10.1186/s40064-015-0951-5 · Cited by 9
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Advances of hydrogel dressings in diabetic wounds
Wang, H., Xu, Z., Zhao, M., Liu, G., & Wu, J. (2021) · Biomaterials Science · doi:10.1039/d0bm01747g · Cited by 354
Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Olejarz, W., Kubiak-Tomaszewska, G., Chrzanowska, A., & Lorenc, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165840 · Cited by 299
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
Ansari, M. J., Bokov, D., Markov, A., Jalil, A. T., Shalaby, M. N., Suksatan, W., Chupradit, S., AL-Ghamdi, H. S., Shomali, N., Zamani, A., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00838-y · Cited by 197
Oncofetal reprogramming in tumour development and progression
Sharma, A., Blériot, C., Currenti, J., & Ginhoux, F. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00497-8 · Cited by 94
Metadata
- Authors
- Aguilar-Cazares, D., Chavez-Dominguez, R., Carlos-Reyes, A., Lopez-Camarillo, C., Hernadez de la Cruz, O. N., & Lopez-Gonzalez, J. S.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-12-12
- Volume
- 9
- Pages
- 1399-1399
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3003604034
- Cited by
- 317
- References
- 97
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.